HIV risk reduction with buprenorphine-naloxone or methadone: findings from a randomized trial.
Woody GE, Bruce D, Korthuis PT, Chhatre S, Poole S, Hillhouse M, Jacobs P, Sorensen J, Saxon AJ, Metzger D, Ling W.
Woody GE, et al. Among authors: metzger d.
J Acquir Immune Defic Syndr. 2014 Jul 1;66(3):288-93. doi: 10.1097/QAI.0000000000000165.
J Acquir Immune Defic Syndr. 2014.
PMID: 24751432
Free PMC article.
Clinical Trial.